|
1
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lee HT, Xue J, Chou PC, Zhou A, Yang P,
Conrad CA, Aldape KD, Priebe W, Patterson C, Sawaya R, et al: Stat3
orchestrates interaction between endothelial and tumor cells and
inhibition of Stat3 suppresses brain metastasis of breast cancer
cells. Oncotarget. 6:10016–10029. 2015.PubMed/NCBI
|
|
3
|
Berclaz G, Altermatt HJ, Rohrbach V,
Siragusa A, Dreher E and Smith PD: EGFR dependent expression of
STAT3 (but not STAT1) in breast cancer. Int J Oncol. 19:1155–1160.
2001.PubMed/NCBI
|
|
4
|
Wang T, Yuan J, Zhang J, Tian R, Ji W,
Zhou Y, Yang Y, Song W, Zhang F and Niu R: Anxa2 binds to STAT3 and
promotes epithelial to mesenchymal transition in breast cancer
cells. Oncotarget. 6:30975–30992. 2015.PubMed/NCBI
|
|
5
|
Xuan X, Li S, Lou X, Zheng X, Li Y, Wang
F, Gao Y, Zhang H, He H and Zeng Q: Stat3 promotes invasion of
esophageal squamous cell carcinoma through up-regulation of MMP2.
Mol Biol Rep. 42:907–915. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Law BY, Mo JF and Wong VK: Autophagic
effects of Chaihu (dried roots of Bupleurum Chinense DC or
Bupleurum scorzoneraefolium WILD). Chin Med. 9:212014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Qi FH, Wang ZX, Cai PP, Zhao L, Gao JJ,
Kokudo N, Li AY, Han JQ and Tang W: Traditional Chinese medicine
and related active compounds: A review of their role on hepatitis B
virus infection. Drug Discov Ther. 7:212–224. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shah AS and Alagawadi KR:
Anti-inflammatory, analgesic and antipyretic properties of
Thespesia populnea Soland ex. Correa seed extracts and its
fractions in animal models. J Ethnopharmacol. 137:1504–1509. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wong VK, Li T, Law BY, Ma ED, Yip NC,
Michelangeli F, Law CK, Zhang MM, Lam KY, Chan PL and Liu L:
Saikosaponin-d, a novel SERCA inhibitor, induces autophagic cell
death in apoptosis-defective cells. Cell Death Dis. 4:e7202013.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang YY, Tang YZ, Fan CL, Luo HT, Guo PR
and Chen JX: Identification and determination of the saikosaponins
in Radix bupleuri by accelerated solvent extraction combined with
rapid-resolution LC-MS. J Sep Sci. 33:1933–1945. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Sai J, Zhao Y, Shan W, Qu B, Zhang Y,
Cheng J, Qu H and Wang Q: Development of an enzyme-linked
immunosorbent assay and immunoaffinity column chromatography for
saikosaponin d using an anti-saikosaponin d monoclonal antibody.
Planta Med. 82:432–439. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lu CN, Yuan ZG, Zhang XL, Yan R, Zhao YQ,
Liao M and Chen JX: Saikosaponin a and its epimer saikosaponin d
exhibit anti-inflammatory activity by suppressing activation of
NF-κB signaling pathway. Int Immunopharmacol. 14:121–126. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Ma Y, Bao Y, Wang S, Li T, Chang X, Yang G
and Meng X: Anti-inflammation effects and potential mechanism of
saikosaponins by regulating nicotinate and nicotinamide metabolism
and arachidonic acid metabolism. Inflammation. 39:1453–1461. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen JC, Chang NW, Chung JG and Chen KC:
Saikosaponin-A induces apoptotic mechanism in human breast
MDA-MB-231 and MCF-7 cancer cells. Am J Chin Med. 31:363–377. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kim BM and Hong SH: Sequential caspase-2
and caspase-8 activation is essential for saikosaponin a-induced
apoptosis of human colon carcinoma cell lines. Apoptosis.
16:184–197. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wong VK, Zhang MM, Zhou H, Lam KY, Chan
PL, Law CK, Yue PY and Liu L: Saikosaponin-d enhances the
anticancer potency of TNF-α via overcoming its undesirable response
of activating NF-Kappa B signalling in cancer cells. Evid Based
Complement Alternat Med. 2013:7452952013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Liu A, Tanaka N, Sun L, Guo B, Kim JH,
Krausz KW, Fang Z, Jiang C, Yang J and Gonzalez FJ: Saikosaponin d
protects against acetaminophen-induced hepatotoxicity by inhibiting
NF-κB and STAT3 signaling. Chem Biol Interact. 223:80–86. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan L, Strasser-Weippl K, Li JJ, St Louis
J, Finkelstein DM, Yu KD, Chen WQ, Shao ZM and Goss PE: Breast
cancer in China. Lancet Oncol. 15:e279–e289. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Lin LT, Chung CY, Hsu WC, Chang SP, Hung
TC, Shields J, Russell RS, Lin CC, Li CF, Yen MH, et al:
Saikosaponin b2 is a naturally occurring terpenoid that efficiently
inhibits hepatitis C virus entry. J Hepatol. 62:541–548. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wieczorek M, Ginter T, Brand P, Heinzel T
and Krämer OH: Acetylation modulates the STAT signaling code.
Cytokine Growth Factor Rev. 23:293–305. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Rössle C, Carpentier YA, Richelle M,
Dahlan W, D'Attellis NP, Fürst P and Elwyn DH: Medium-chain
triglycerides induce alterations in carnitine metabolism. Am J
Physiol. 258:E944–E947. 1990.PubMed/NCBI
|
|
22
|
Ni Z, Lou W, Leman ES and Gao AC:
Inhibition of constitutively activated Stat3 signaling pathway
suppresses growth of prostate cancer cells. Cancer Res.
60:1225–1228. 2000.PubMed/NCBI
|
|
23
|
Gao L, Zhang L, Hu J, Li F, Shao Y, Zhao
D, Kalvakolanu DV, Kopecko DJ, Zhao X and Xu DQ: Down-regulation of
signal transducer and activator of transcription 3 expression using
vector-based small interfering RNAs suppresses growth of human
prostate tumor in vivo. Clin Cancer Res. 11:6333–6341. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lacayo CI, Pincus Z, VanDuijn MM, Wilson
CA, Fletcher DA, Gertler FB, Mogilner A and Theriot JA: Emergence
of large-scale cell morphology and movement from local actin
filament growth dynamics. PLoS Biol. 5:e2332007. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chhabra ES and Higgs HN: The many faces of
actin: Matching assembly factors with cellular structures. Nat Cell
Biol. 9:1110–1121. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bear JE and Gertler FB: Ena/VASP: Towards
resolving a pointed controversy at the barbed end. J Cell Sci.
122:1947–1953. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Mook OR, Frederiks WM and Van Noorden CJ:
The role of gelatinases in colorectal cancer progression and
metastasis. Biochim Biophys Acta. 1705:69–89. 2004.PubMed/NCBI
|
|
28
|
Jezierska A and Motyl T: Matrix
metalloproteinase-2 involvement in breast cancer progression: A
mini-review. Med Sci Monit. 15:RA32–RA40. 2009.PubMed/NCBI
|
|
29
|
Zhou R, Xu L, Ye M, Liao M, Du H and Chen
H: Formononetin inhibits migration and invasion of MDA-MB-231 and
4T1 breast cancer cells by suppressing MMP-2 and MMP-9 through
PI3K/AKT signaling pathways. Horm Metab Res. 46:753–760. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xie TX, Wei D, Liu M, Gao AC, Ali-Osman F,
Sawaya R and Huang S: Stat3 activation regulates the expression of
matrix metalloproteinase-2 and tumor invasion and metastasis.
Oncogene. 23:3550–3560. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Dechow TN, Pedranzini L, Leitch A, Leslie
K, Gerald WL, Linkov I and Bromberg JF: Requirement of matrix
metalloproteinase-9 for the transformation of human mammary
epithelial cells by Stat3-C. Proc Natl Acad Sci USA.
101:10602–10607. 2004. View Article : Google Scholar : PubMed/NCBI
|
